Getinge exits surgical perfusion, creating opportunity for Livanova [Yahoo! Finance]
LivaNova PLC - Ordinary Shares (LIVN)
Last livanova plc - ordinary shares earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
livanova.com
Company Research
Source: Yahoo! Finance
· Courtesy of Getinge Nick Paul Taylor Thu, January 30, 2025 at 10:59 AM GMT+1 3 min read In This Article GNGBY This story was originally published on MedTech Dive . To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter Dive Brief: Getinge said Tuesday it will phase out its surgical perfusion business and reallocate resources to higher-growth areas such as extracorporeal membrane oxygenation (ECMO) and transplant care. CEO Mattias Perjos said on an earnings call that surgical perfusion has “been a struggling category” since a consent decree forced Getinge off the U.S. surgical perfusion market in 2015. Needham and Stifel analysts framed the news as a positive for Livanova, which they expect to compete for the 450 million Swedish krona (about $41 million) in sales in 2024 that Getinge is giving up on. Dive Insight: Getinge signed a consent decree with the Food and Drug Administration in 2015, agreeing to temporarily suspend p
Show less
Read more
Impact Snapshot
Event Time:
LIVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LIVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LIVN alerts
High impacting LivaNova PLC - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
LIVN
News
- LivaNova to Present at J.P. Morgan Healthcare Conference in January [Yahoo! Finance]Yahoo! Finance
- LivaNova to Present at J.P. Morgan Healthcare Conference in JanuaryBusiness Wire
- Cadence Neuroscience Announces Medical Device Veteran Daniel Moore as Independent Board DirectorPR Web
- LivaNova (NASDAQ:LIVN) was upgraded by analysts at KeyCorp to a "strong-buy" rating.MarketBeat
- Building a More Inclusive Future: Mediaplanet Launches "Disability Empowerment" Campaign [Yahoo! Finance]Yahoo! Finance
LIVN
Earnings
- 11/5/25 - Beat
LIVN
Sec Filings
- 12/17/25 - Form 4
- 12/17/25 - Form 4
- 12/17/25 - Form 4
- LIVN's page on the SEC website